These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11249011)

  • 21. Mass spectrometric analysis to unravel the venom proteome composition of Indian snakes: opening new avenues in clinical research.
    Chanda A; Mukherjee AK
    Expert Rev Proteomics; 2020 May; 17(5):411-423. PubMed ID: 32579411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of an endogenous inhibitor of phospholipase A2 from Indian cobra (Naja naja naja) venom.
    Rudrammaji LM; Gowda TV
    Toxicon; 1998 Apr; 36(4):639-44. PubMed ID: 9643477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Simple and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia.
    Ratanabanangkoon K; Tan KY; Eursakun S; Tan CH; Simsiriwong P; Pamornsakda T; Wiriyarat W; Klinpayom C; Tan NH
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004565. PubMed ID: 27058956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological cross-reactivity and neutralization of the principal toxins of Naja sumatrana and related cobra venoms by a Thai polyvalent antivenom (Neuro Polyvalent Snake Antivenom).
    Leong PK; Fung SY; Tan CH; Sim SM; Tan NH
    Acta Trop; 2015 Sep; 149():86-93. PubMed ID: 26026717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biogeographical venom variation in the Indian spectacled cobra (Naja naja) underscores the pressing need for pan-India efficacious snakebite therapy.
    Senji Laxme RR; Attarde S; Khochare S; Suranse V; Martin G; Casewell NR; Whitaker R; Sunagar K
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009150. PubMed ID: 33600405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.
    Zdenek CN; den Brouw BO; Dashevsky D; Gloria A; Youngman NJ; Watson E; Green P; Hay C; Dunstan N; Allen L; Fry BG
    Toxicol Lett; 2019 Nov; 316():171-182. PubMed ID: 31442586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes.
    Arce V; Rojas E; Ownby CL; Rojas G; Gutiérrez JM
    Toxicon; 2003 Jun; 41(7):851-60. PubMed ID: 12782085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic analysis to unravel the complex venom proteome of eastern India Naja naja: Correlation of venom composition with its biochemical and pharmacological properties.
    Dutta S; Chanda A; Kalita B; Islam T; Patra A; Mukherjee AK
    J Proteomics; 2017 Mar; 156():29-39. PubMed ID: 28062377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymatic activity and brine shrimp lethality of venom from the large brown spitting cobra (Naja ashei) and its neutralization by antivenom.
    Okumu MO; Mbaria JM; Gikunju JK; Mbuthia PG; Madadi VO; Ochola FO
    BMC Res Notes; 2020 Jul; 13(1):325. PubMed ID: 32631407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structures of an acidic phospholipase A(2) from the venom of Naja Kaouthia.
    Gu L; Wang Z; Song S; Shu Y; Lin Z
    Toxicon; 2002 Jul; 40(7):917-22. PubMed ID: 12076645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region-specific neutralization of Indian cobra (Naja naja) venom by polyclonal antibody raised against the eastern regional venom: A comparative study of the venoms from three different geographical distributions.
    Shashidharamurthy R; Kemparaju K
    Int Immunopharmacol; 2007 Jan; 7(1):61-9. PubMed ID: 17161818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-clinical assessment of the effectiveness of modified polyvalent antivenom in the neutralization of Naja naja venom toxicity.
    Kadali R; Kadiyala G; Gurunathan J
    Biotechnol Appl Biochem; 2016 Nov; 63(6):827-833. PubMed ID: 26300538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of in vitro methods for assessing the potency of therapeutic antisera against the venom of the coral snake Micrurus nigrocinctus.
    Alape-Girón A; Miranda-Arrieta K; Cortes-Bratti X; Stiles BG; Gutiérrez JM
    Toxicon; 1997 Apr; 35(4):573-81. PubMed ID: 9133712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geographical venom variations of the Southeast Asian monocled cobra (Naja kaouthia): venom-induced neuromuscular depression and antivenom neutralization.
    Tan KY; Tan CH; Sim SM; Fung SY; Tan NH
    Comp Biochem Physiol C Toxicol Pharmacol; 2016; 185-186():77-86. PubMed ID: 26972756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental evaluation of ovine antisera to Thai cobra (Naja kaouthia) venom and its alpha-neurotoxin.
    Sells PG; Jones RG; Laing GD; Smith DC; Theakston RD
    Toxicon; 1994 Dec; 32(12):1657-65. PubMed ID: 7725333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of quality, safety, and pre-clinical toxicity of an equine polyvalent anti-snake venom (Pan Africa): Determination of immunological cross-reactivity of antivenom against venom samples of Elapidae and Viperidae snakes of Africa.
    Patra A; Kalita B; Mukherjee AK
    Toxicon; 2018 Oct; 153():120-127. PubMed ID: 30189243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a cell-based assay to differentiate between the cytotoxic effects of elapid snake venoms.
    Kalam Y; Isbister GK; Mirtschin P; Hodgson WC; Konstantakopoulos N
    J Pharmacol Toxicol Methods; 2011; 63(2):137-42. PubMed ID: 20849965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp., Elapidae) and its neutralization by a polyspecific antivenom.
    Méndez I; Gutiérrez JM; Angulo Y; Calvete JJ; Lomonte B
    Toxicon; 2011 Nov; 58(6-7):558-64. PubMed ID: 21924279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms.
    Ramos HR; Vassão RC; de Roodt AR; Santos E Silva EC; Mirtschin P; Ho PL; Spencer PJ
    Clin Toxicol (Phila); 2017 Jan; 55(1):33-39. PubMed ID: 27595162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.